Pharmaceutical

Image

Europe Contract Manufacturing Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Apr 2023
  • Europe
  • 350 Pages
  • No of Tables: 201
  • No of Figures: 31

Europe Contract Manufacturing Market, By Product (Pharmaceutical Products Manufacturing and Medical Device Manufacturing), By End User (Pharmaceutical Companies, Biotechnology Companies, Biopharma Companies, Medical Device Companies, Original Equipment Manufacturer, and Research Institutes), By Distribution Channel (Retail Sales, Direct Tender, and Others) - Industry Trends and Forecast to 2030.

Europe Contract Manufacturing Market

Europe Contract Manufacturing Market Analysis and Insights

Europe contract manufacturing market is driven by the factors such as, rising technical advancements and cost effectiveness of pharmaceutical and pipeline products enhances its demand as well as rising investment in research and development leads to the market growth. Currently, healthcare expenditure has increased across developed and emerging countries that is expected to create a competitive advantage for manufacturers to develop new and innovative products.

Europe Contract Manufacturing MarketEurope Contract Manufacturing Market

Contract manufacturing is a contract between a company and a manufacturer to make a certain number of components or products for the company in a specified period of time. The goods created will be under the company’s label or brand. This is called private label manufacturing. This is often also called outsourcing if it is done across borders. Manufacturers provide their service based on their own designs, formulas, and specifications unless the customer provides its own. They will create these products to whomever they have contracted with, even competing firms.

One of the primary factors driving the growth of the contract manufacturing market is the rising demand in medical device & pharmaceutical sector. The continuing clinical trial research being conducted by several companies for better diagnosis leads to market expansion. The market is also influenced by the rising technological advancements and cost effectiveness. However, the risk of confidential information and stringent regulations may act as restraining factors for the Europe Contract Manufacturing Market in the forecast period

On the other hand, patent expiry and increasing demand for generic drugs, growing expenses in healthcare infrastructure and strategic initiatives by key market players act as an opportunity for the growth of the market. However, the intellectual property risk and increasing number of pharmaceutical companies to set up their own manufacturing units may create challenges for the Europe Contract Manufacturing Market.

The demand for contract manufacturing will increase in Europe due to an increasing inclination toward point-of-care diagnostics. Various companies are taking initiatives that gradually lead to the growth of the market.

Europe Contract Manufacturing market is supportive and aims to reduce the manufacturing efforts of the healthcare organizations. Data Bridge Market Research analyses that Europe contract manufacturing market will grow at a CAGR of 6.0% during the forecast period of 2023 to 2030.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015- 2020)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Product (Pharmaceutical Products Manufacturing and Medical Device Manufacturing), By End User (Pharmaceutical Companies, Biotechnology Companies, Biopharma Companies, Medical Device Companies, Original Equipment Manufacturer, and Research Institutes), By Distribution Channel (Retail Sales, Direct Tender, and Others)

Countries Covered

Germany, France, Italy, the U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, Rest of Europe

Market Players Covered

Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH., and Catalent, Inc among others

Europe Contract Manufacturing Dynamics

Market Definition

Contract manufacturing in international markets is used in situations when one company arranges for another company in a different country to manufacture its products; this is also known as international subcontracting or international outsourcing. The company provides the manufacturer with all the specifications, and, if applicable, also with the materials required for the production process. This type of contract sets out the requirements, which the manufacturer must meet concerning the quality of the products, certification, quantities, conditions and dates of delivery, etc. It also establishes guidelines for the inspection and testing of the products set forth by the company which contracts out the manufacture, or by its own clients. Furthermore, it also outlines modifications to orders, as well as guarantees and compensation in case of breach of contract. Since the process is essentially outsourcing production in foreign markets to a partner that privately brands the end product, there are a number of different companies and industries that can make use of this type of contract.

Drivers

  • Cost-effectiveness for the manufacturing companies

The time-consuming manufacturing and ineffective production for several things and management are major burdens for public and private sector organizations. They are also essential for addressing complex challenges because a single organization is less effective in driving the change and sometimes required outcomes. The contract manufacturing companies will act as rising opportunities for both governmental and private sectors

The rising demand for contract manufacturing with improved accuracy and less time constraint pushes the key players for strategic initiatives. Owning contract manufacturing frees up the overhead charges required to invest in machinery, material, and another workforce, simplifying the production process and streamlining the supply chain by reducing the overall cost.

However, major market players are investing heavy capital in manufacturing to reach the demands of their end users. The contract manufacturing players are involved in making the strategies and implementing them by reducing the cost of production of these players. Contract manufacturing services to other firms also ensure efficiency and optimum usage of resources by using effective workforce, strategic intelligence, or working resources required in the production cycle.

  • Rise of technological advancements in contract manufacturing

Introducing a new drug in the market promptly requires considerable investments in manufacturing due to the escalated demand in the pharmaceutical industry. Advanced technologies and skills are mandatory as some drugs have complex formulas and require specific equipment and techniques when mass-produced.

The usage of innovative technologies such as machine learning, big data, and artificial intelligence to develop pharmaceutical drugs or manufacture medical devices are being considered for rapid and quick manufacturing. These technical advancements also help in mass production and scalability in a short span of time.

However, pharmaceutical firms conventionally audit or supervise their contract manufacturing organization's production and delivery processes to monitor the manufacturing process using real-time remote tracing.

Opportunities

  • Growing expenses on the development of healthcare infrastructure

Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population. Infrastructure must integrate the hospital, as the center for acute and inpatient care, into the broader healthcare system and should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements: equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff.

However, the growing expenses on the development of healthcare infrastructure are propelling the growth of the Europe contract manufacturing market in the forecast period.

Restraints/Challenges

  • Increase in the Number of Pharmaceutical Companies Set Up Their Manufacturing Sites

Most pharmaceutical companies are building manufacturing sites to produce pharmaceutical products to reduce costs. Manufacturers are more focused on introducing advanced technologies and the digitalization process. The Pharma industry also faces disruptions due to new business models and a more focused population on personalized medicines and treatments. Hence, the demand for personalized care is high. Occupational profiles are also changing: some jobs are disappearing due to automation while entirely new jobs are emerging.

Hence, the increasing number of pharmaceutical companies setting up their manufacturing units may challenge the growth of the Europe contract manufacturing market in the forecast period.

Recent Developments

  • In October 2021, Boehringer Ingelheim International gmbh., had inaugurated its state-of-the-art biopharmaceutical production facility Large Scale Cell Culture (LSCC) in Vienna, Austria, with an investment volume of more than 700 million EUR, which is the single largest investment in the company's history
  • In March 2023, Evonik Industries AG has announced that it is opening a new GMP facility to manufacture lipids for advanced, pharmaceutical drug delivery applications. The lipid launch facility is located at the company’s site in Hanau, Germany and provides customers with quantities of lipids as needed for clinical and small-scale commercial manufacturing

Europe Contract Manufacturing Market Segmentation

The Europe contract manufacturing market is categorized into three notable segments based on product, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product

  • Medical Device Manufacturing
  • Pharmaceutical Products Manufacturing

On the basis of product, the Europe contract manufacturing market is segmented into medical device manufacturing and pharmaceutical products manufacturing.

End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Biopharma Companies
  • Medical Device Companies
  • Original Equipment Manufacturer
  • Research Institutes

On the basis of end user, the Europe contract manufacturing market is segmented into original equipment manufacturer, medical device companies, pharmaceutical companies, biotechnology companies, biopharma companies, and research institutes.

Distribution Channel

  • Retail Sales
  • Direct Tender
  • Others

On the basis of distribution channel, the Europe contract manufacturing market is segmented into direct tenders, retail sales, and others.

Contract Manufacturing Market

Europe Contract Manufacturing Market Regional Analysis/Insights

The Europe contract manufacturing market is analyzed, and market size insights and trends are provided by product, end user, and distribution channel as referenced above.

Some countries covered in the Europe contract manufacturing report are Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, Rest of Europe.

The U.K. is expected to dominate due to increasing technological advancement in the developing areas.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Contract Manufacturing Market Share Analysis

The Europe contract manufacturing market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Europe contract manufacturing market.

Some players in the market are Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH. and Catalent, Inc among others.


SKU-

TABLE 1 EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 2 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 4 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 5 EUROPE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 6 EUROPE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 7 EUROPE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 8 EUROPE MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 EUROPE CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 EUROPE TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 12 EUROPE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 13 EUROPE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 14 EUROPE PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 EUROPE BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 EUROPE BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 EUROPE AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 EUROPE ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 EUROPE RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 20 EUROPE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 21 EUROPE RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 EUROPE DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 EUROPE OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 24 EUROPE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 25 EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 26 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 27 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 28 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT)

TABLE 29 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP)

TABLE 30 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 31 EUROPE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 32 EUROPE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 33 EUROPE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 34 EUROPE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 35 EUROPE TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 36 EUROPE TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 37 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 38 EUROPE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 39 EUROPE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 40 EUROPE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 41 GERMANY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 42 GERMANY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 43 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 44 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 45 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 46 GERMANY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 47 GERMANY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 48 GERMANY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 49 GERMANY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 50 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 51 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 52 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 53 GERMANY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 54 GERMANY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 55 GERMANY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 56 GERMANY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 57 FRANCE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 58 FRANCE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 59 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 60 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 61 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 62 FRANCE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 63 FRANCE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 64 FRANCE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 65 FRANCE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 66 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 67 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 68 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 69 FRANCE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 70 FRANCE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 71 FRANCE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 72 FRANCE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 73 U.K. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 74 U.K. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 75 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 76 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 77 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 78 U.K. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 79 U.K. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 80 U.K. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 81 U.K. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 82 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 83 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 84 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 85 U.K. TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 86 U.K. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 87 U.K. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 88 U.K. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 89 ITALY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 90 ITALY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 91 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 92 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 93 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 94 ITALY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 95 ITALY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 96 ITALY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 97 ITALY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 98 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 99 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 100 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 101 ITALY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 102 ITALY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 103 ITALY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 104 ITALY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 105 SPAIN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 106 SPAIN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 107 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 108 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 109 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 110 SPAIN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 111 SPAIN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 112 SPAIN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 113 SPAIN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 114 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 115 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 116 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 117 SPAIN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 118 SPAIN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 119 SPAIN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 120 SPAIN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 121 RUSSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 RUSSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 123 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 124 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 125 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 126 RUSSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 127 RUSSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 RUSSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 129 RUSSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 130 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 131 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 132 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 133 RUSSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 134 RUSSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 135 RUSSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 136 RUSSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 137 TURKEY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 138 TURKEY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 139 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 140 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 141 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 142 TURKEY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 143 TURKEY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 144 TURKEY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 145 TURKEY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 146 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 147 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 148 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 149 TURKEY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 150 TURKEY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 151 TURKEY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 152 TURKEY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 153 BELGIUM CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 154 BELGIUM PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 155 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 156 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 157 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 158 BELGIUM BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 159 BELGIUM BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 160 BELGIUM LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 161 BELGIUM MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 163 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 164 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 165 BELGIUM TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 166 BELGIUM BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 167 BELGIUM CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 168 BELGIUM CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 169 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 170 NETHERLANDS PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 171 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 172 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 173 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 174 NETHERLANDS BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 175 NETHERLANDS BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 176 NETHERLANDS LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 177 NETHERLANDS MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 178 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 179 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 180 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 181 NETHERLANDS TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 182 NETHERLANDS BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 183 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 184 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 185 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 186 SWITZERLAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 187 SWITZERLAND TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 188 SWITZERLAND TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 189 SWITZERLAND TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 190 SWITZERLAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 191 SWITZERLAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 192 SWITZERLAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 193 SWITZERLAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 194 SWITZERLAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 195 SWITZERLAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)

TABLE 196 SWITZERLAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 197 SWITZERLAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 198 SWITZERLAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 199 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 200 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 201 REST OF EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Contract Manufacturing Market is projected to grow at a CAGR of 6.0% during the forecast period by 2030.
The Europe Contract Manufacturing Market is segmented on the basis of product, end user and distribution channel.
The major players in the Europe Contract Manufacturing Market are Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH., and Catalent, Inc. among others.
The countries covered in the Europe Contract Manufacturing Market are Germany, France, Italy, the U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, Rest of Europe.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials